Magnetic separation device for cell sorting and analysis

• US 8,481,336 B2
• Filed: 09/09/2010
• Issued: 07/09/2013
• Est. Priority Date: 09/09/2009
• Status: Active Grant

• Current Assignee: Board of Trustees of the Leland Stanford Junior University (Stanford Management Co.)
• Original Assignee: Board of Trustees of the Leland Stanford Junior University (Stanford Management Co.)
• Inventors: Earhart, Christopher M., Wang, Shan X., Wilson, Robert J.
• Primary Examiner(s): Shibuya, Mark
• Assistant Examiner(s): DO, PENSEE T
• Application Number:
  US12/807,625
• Publication Number:
  US 20110059468A1
• Time in Patent Office: 1,034 Days
• Field of Search: 436/526, 435/4, 210/321.6, 210/500.27, 210/488
• US Class Current: 436/526
• CPC Class Codes: C12N 13/00 Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
• CPC Class Codes: G01N 33/54333 Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
• CPC Class Codes: G01N 33/56966 Animal cells
• CPC Class Codes: G01N 33/57488 involving compounds identifable in body fluids

Abstract

A magnetic sifter is adapted for manipulation of biological cells by providing a greater pore density at the edge of the sifter than at the center. Application of an external magnetic field to the sifter causes high magnetic fields and field gradients at the sifter pores. These conditions are suitable for capturing magnetically tagged or labeled cells at the sifter pores. Altering the external magnetic field can provide controlled capture and/or release of magnetically labeled cells from the sifter pores. The purpose of having a greater pore density at the periphery of the sifter than at the center is to provide improved flow rate uniformity through the sifter. Such flow rate uniformity is advantageous for cell quantification.

Claims

1. An apparatus for manipulating biological cells, the apparatus comprising:

a substrate including a plurality of through holes and having a central region and a peripheral region around the central region, wherein the through holes have a higher density in the peripheral region than in the central region;

one or more soft magnetic layers disposed on the substrate and in proximity to the through holes; and

a magnetic source, wherein the magnetic source is capable of controlling a magnetic field strength and/or a magnetic field gradient provided by the soft magnetic layers.

2. The apparatus of claim 1, wherein a distribution of the through holes is selected such that flow rates through the holes are substantially the same when fluid passes through the substrate via the holes.

3. The apparatus of claim 1, wherein the shapes of the through holes are selected from the group consisting of:

square holes, rectangular holes, circular holes, and bow-tie holes.

4. The apparatus of claim 1, further comprising a non-magnetic spacer layer disposed to reduce magnetic leakage flux at the soft magnetic layers when the soft magnetic layers are in a demagnetized state.

5. The apparatus of claim 1, further comprising an anti-fouling layer disposed at the through holes and substrate.

6. The apparatus of claim 1, further comprising a flow cell in which the substrate is disposed, wherein the flow cell includes an optical window in proximity to the through holes.

7. The apparatus of claim 1, wherein the magnetic source comprises an electromagnetic source or a permanent magnet.

8. A method for manipulating biological cells, the method comprising:

providing a substrate including a plurality of through holes and having a central region and a peripheral region around the central region, wherein the through holes have a higher density in the peripheral region than in the central region;

providing one or more soft magnetic layers disposed on the substrate and in proximity to the through holes;

tagging biological cells with one or more magnetic tags to provide tagged cells;

passing a fluid including the tagged cells through the holes of the substrate; and

capturing and/or releasing the tagged cells at the through holes by applying an external magnetic field to control a magnetic field strength and/or a magnetic field gradient provided by the soft magnetic layers.

9. The method of claim 8, wherein a distribution of the through holes is selected such that flow rates through the holes are substantially the same.

10. The method of claim 8, wherein the releasing tagged cells comprises one or more methods selected from the group consisting of:

altering the magnetic field direction at the magnets by about 90 degrees;

setting the external magnetic field to about zero;

reducing the external magnetic field to about zero in a manner that provides demagnetization of the magnets, and mechanically agitating the substrate and/or fluid passing through the holes.

11. The method of claim 8, further comprising quantifying cells that are captured at the through holes.

12. The method of claim 11, wherein the quantifying cells includes providing one or more fluorescent markers that bind to specific cell types.

13. A method for manipulating biological cells, the method comprising:

first performing the method of claim 8 to provide a processed cell stream;

second performing the method of claim 8 one or more additional times on the processed cell stream.

14. The method of claim 13, wherein the magnetic tags for the first performing differ from the magnetic tags for the second performing.

15. A method for clinical evaluation comprising:

capturing cells from a patient blood sample according to the method of claim 8 to provide captured cells; and

quantifying the captured cells.

16. The method of claim 15, wherein the quantifying the captured cells includes providing a first fluorescent marker that binds specifically to a first cell type, a second fluorescent marker that binds specifically to a second cell type, and a third fluorescent marker that binds specifically to both the first cell type and the second cell type.

17. A method for clinical evaluation of cancer comprising clinically evaluating circulating tumor cells according to the method of claim 15.

18. A method for clinical evaluation of disease states comprising clinically evaluating lymphocytes according to the method of claim 15.